For the Inventor, By the Inventor

Enter assignee name

Hannover, Germany

Solvay Pharmaceuticals, Gmbh

USPTO Granted Patents = 77

CIPO Patents = 6

EPO Patents = 2

Trademarks = 8

Forward Citations = 476

Loading Chart...

Loading Chart...

168 inventors (with patents filed for the assignee):

Jochen Antel (17 out of 18 patents)

Dieter Ziegler (14 out of 23 patents)

Reinhard Brueckner (11 out of 18 patents)

4. Michael Weske (10 out of 15 patents)

5. Harald Waldeck (10 out of 11 patents)

6. Holger Sann (10 out of 10 patents)

7. Josef Messinger (9 out of 14 patents)

8. Ulf Preuschoff (9 out of 16 patents)

9. Uwe Schoen (7 out of 22 patents)

10. Yvan Fischer (7 out of 8 patents)

11. Daniel Jasserand (7 out of 7 patents)

12. Samuel David (7 out of 20 patents)

13. Christian Eeckhout (7 out of 9 patents)

14. Cornelis G Kruse (6 out of 54 patents)

15. Michael Wurl (6 out of 8 patents)

Core Competencies:

Protease Variants

Estratriene Derivatives

Amylases

5-HT Receptor Antagonists

NEP-Inhibitors

Cannabinoid Receptor Modulators

Piperazine Compounds

BRS-3 Agonists

Oxidative Protective Compositions

Diabetes Treatment

Conjugated Estrogens

Urine Collection Devices

77 patents: Sort by Forward Citations

1. 8455235 - Protease variants for pharmaceutical use (2013-06-04),

2. 8288367 - Substituted estratriene derivatives as 17BETA HSD inhibitors (2012-10-16),

3. 8017351 - Amylases for pharmaceutical use (2011-09-13),

4. 7820690 - Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist (2010-10-26),

5. 7816347 - Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors (2010-10-19),

6. 7772225 - N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions (2010-08-10),

7. 7767692 - 1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds (2010-08-03),

8. 7763607 - Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators (2010-07-27),

9. 7714150 - [object Object] (2010-05-11),

10. 7605162 - Phenylpiperazine (2009-10-20),

11. 7592344 - NK1 and NK2-antagonists and compositions and methods of using the same (2009-09-22),

12. 7547708 - N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof (2009-06-16),

13. 7534903 - [object Object] (2009-05-19),

14. 7524853 - Compounds and their use in therapy (2009-04-28),

15. 7524833 - Method and apparatus for concentrating and stabilizing conjugated estrogens from mare urine (2009-04-28),

Solvay Pharmaceuticals, GmbH is a global pharmaceutical company that focuses on developing and manufacturing innovative healthcare solutions. With a presence in multiple countries, Solvay Pharmaceuticals aims to improve the well-being of individuals all over the world. Their extensive range of products includes prescription drugs, over-the-counter medicines, and medical devices. Committed to research and development, Solvay Pharmaceuticals strives to discover new therapeutic approaches and advance medical science. By combining cutting-edge technology and scientific expertise, they constantly strive to provide effective and safe solutions that meet the diverse needs of patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

77 Patents

#15 in Hannover

#778 in Germany

#9,534 in the World

Hannover, Germany

Solvay Pharmaceuticals, Gmbh

Forward Citations = 476

168 inventors:

Jochen Antel (17 out of 18 patents)

Dieter Ziegler (14 out of 23 patents)

Reinhard Brueckner (11 out of 18 patents)

4. Michael Weske (10 out of 15 patents)

5. Harald Waldeck (10 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…